Literature DB >> 3734111

Prostatic adenocarcinoma evolving into carcinoid: selective effect of hormonal treatment?

M Stratton, D J Evans, I A Lampert.   

Abstract

Two patients, aged 72 and 65 years, each underwent two prostatic resections spaced four and two years apart, respectively. In both cases the earlier procedure showed widespread adenocarcinoma with only occasional endocrine cells, while tissue from the later operations showed prostatic carcinoids. It is suggested that the conventional adenocarcinomas were sensitive to hormonal manipulations used in treatment, but that the originally sparse carcinoid components were resistant to this form of treatment and hence became the predominant tumours. These findings imply that endocrine differentiation in prostatic carcinoma leads to lack of sex steroid sensitivity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3734111      PMCID: PMC500036          DOI: 10.1136/jcp.39.7.750

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Squamous metaplasia of prostate following estrogen therapy.

Authors:  A R BAINBOROUGH
Journal:  J Urol       Date:  1952-07       Impact factor: 7.450

2.  Argentaffin and argyrophil cells in the prostate.

Authors:  B A Kazzaz
Journal:  J Pathol       Date:  1974-03       Impact factor: 7.996

3.  Argentaffin cells in prostatic carcinoma: differentiation from lipofuscin and melanin in prostatic epithelium.

Authors:  J G Azzopardi; D J Evans
Journal:  J Pathol       Date:  1971-08       Impact factor: 7.996

4.  Inappropriate secretion of antidiuretic hormone by carcinoma of the prostate.

Authors:  R A Sellwood; J Spencer; J G Azzopardi; S Wapnick; R B Welbourn; A E Kulatilake
Journal:  Br J Surg       Date:  1969-12       Impact factor: 6.939

5.  Diffuse carcinoid of prostate.

Authors:  P W Wasserstein; R L Goldman
Journal:  Urology       Date:  1981-10       Impact factor: 2.649

6.  Carcinoid tumor of the prostate associated with adenocarcinoma.

Authors:  A Y Montasser; M G Ong; V T Mehta
Journal:  Cancer       Date:  1979-07       Impact factor: 6.860

7.  Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia.

Authors:  R E Wenk; B S Bhagavan; R Levy; D Miller; W Weisburger
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

8.  The endocrine component of prostatic carcinomas, mixed adenocarcinoma-carcinoid tumours and non-tumour prostate. Histochemical and ultrastructural identification of the endocrine cells.

Authors:  C Capella; L Usellini; R Buffa; B Frigerio; E Solcia
Journal:  Histopathology       Date:  1981-03       Impact factor: 5.087

9.  Primary carcinoid of prostate.

Authors:  P W Wasserstein; R L Goldman
Journal:  Urology       Date:  1979-03       Impact factor: 2.649

10.  Primary prostatic carcinoid tumor with intracytoplasmic prostatic acid phosphatase and prostate-specific antigen.

Authors:  N Azumi; H Shibuya; M Ishikura
Journal:  Am J Surg Pathol       Date:  1984-07       Impact factor: 6.394

View more
  7 in total

1.  Composite enteric-type adenocarcinoma-carcinoid of the nasal mucosa.

Authors:  Marzia Bonato; Bruno Frigerio; Carlo Capelia; Anna Maria Chiaravalli; Michele Cerati
Journal:  Endocr Pathol       Date:  1993-03       Impact factor: 3.943

2.  Interventional genetics and cancer treatment.

Authors:  D J Evans
Journal:  BMJ       Date:  1993-04-17

3.  A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

Authors:  Lawrence D True; Kent Buhler; Janna Quinn; Emily Williams; Peter S Nelson; Nigel Clegg; Jill A Macoska; Thomas Norwood; Alvin Liu; William Ellis; Paul Lange; Robert Vessella
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

4.  Do neuroendocrine cells in human prostate cancer express androgen receptor?

Authors:  J L Krijnen; P J Janssen; J A Ruizeveld de Winter; H van Krimpen; F H Schröder; T H van der Kwast
Journal:  Histochemistry       Date:  1993-11

Review 5.  Small cell carcinoma of the prostate.

Authors:  Rosa Nadal; Michael Schweizer; Oleksandr N Kryvenko; Jonathan I Epstein; Mario A Eisenberger
Journal:  Nat Rev Urol       Date:  2014-02-18       Impact factor: 14.432

6.  Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.

Authors:  Jonathan I Epstein; Mahul B Amin; Himisha Beltran; Tamara L Lotan; Juan-Miguel Mosquera; Victor E Reuter; Brian D Robinson; Patricia Troncoso; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

Review 7.  Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate.

Authors:  M A Noordzij; G J van Steenbrugge; T H van der Kwast; F H Schröder
Journal:  Urol Res       Date:  1995
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.